Pharos : Ligand Details - erdafitinib

You are using an outdated browser. Please upgrade your browser to improve your experience.

Erdafitinib inhibited FGFR phosphorylation and signaling and decreased cell viability in cell lines expressing FGFR genetic alterations, including point mutations, amplifications, and fusions. Erdafitinib demonstrated antitumor activity in FGFR-expressing cell lines and xenograft models derived from tumor types, including bladder cancer.

Ligand Summary

Ligand Structure

chemical structure image

Synonyms & Links

UNII: 890E37NHMV

PubChem: 67462786

Guide to Pharmacology: 9039

ChEMBL: CHEMBL3545376

DrugCentral: 5327

LyCHI: YQ15HNNJQ6JG

Target Activities

Items per page:

10

1 – 5 of 5

FGFR3

Tclin

Fibroblast growth factor receptor 3

6 Activities

Items per page:

1 – 6 of 6

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)
IC50	7.8

IC50	7.8		None, (2014) None:None:None

IC50	8.42

IC50	8.42		None, (2014) None:None:None

IC50	8.52000046

IC50	8.5229	INHIBITOR	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf

FGFR4

Tclin

Fibroblast growth factor receptor 4

4 Activities

Items per page:

1 – 4 of 4

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)
IC50	8.18

IC50	8.18		None, (2014) None:None:None

IC50	8.25

IC50	8.2441	INHIBITOR	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf

FGFR2

Tclin

Fibroblast growth factor receptor 2

4 Activities

Items per page:

1 – 4 of 4

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)
IC50	8.35

IC50	8.35		None, (2014) None:None:None

IC50	8.64000034

IC50	8.6021	INHIBITOR	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf

FGFR1

Tclin

Fibroblast growth factor receptor 1

4 Activities

Items per page:

1 – 4 of 4

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)
IC50	8.73

IC50	8.73		None, (2014) None:None:None

IC50	8.93999958

IC50	8.9208	INHIBITOR	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf

KDR

Tclin

Vascular endothelial growth factor receptor 2

2 Activities

Items per page:

1 – 2 of 2

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)
IC50	7.44000006

IC50	7.4342	INHIBITOR	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf